Who Profits When Health Is the Story

The fact almost nobody knows

Only two industrialized countries permit direct-to-consumer advertising of prescription medicines: the United States and New Zealand [1]. That is not a talking point, it is the starting condition. Everywhere else, a pharmaceutical company can market to doctors but not to you. So the environment most American readers assume is normal -- drug names in the middle of the evening news, a condition you had not heard of and a medication for it in the same thirty seconds -- is an outlier arrangement that the rest of the developed world looked at and declined.

The size of it, in public data

The money is not hidden either. A twenty-year review published in JAMA found that United States medical marketing spending -- prescription drugs, disease awareness campaigns, health services and laboratory testing -- rose from 17.7 billion dollars in 1997 to 29.9 billion in 2016, and that direct-to-consumer advertising was the single fastest-growing component of it [2]. An earlier analysis found total pharmaceutical promotion grew from 11.4 to 29.9 billion dollars between 1996 and 2005, with direct-to-consumer spending up 330 percent over that period, while the number of warning letters the regulator sent about advertising violations fell from 142 a year to 21 [3]. And television is where a large share of it lands: TV accounts for more than half of United States direct-to-consumer advertising spending [4].

• Only two industrialized countries allow prescription drug advertising direct to the public.
• US medical marketing: 17.7 billion dollars in 1997 to 29.9 billion in 2016, DTC the fastest-growing part.
• DTC spending rose 330 percent from 1996 to 2005 while regulator warning letters fell from 142 to 21 a year.
• Television carries more than half of US direct-to-consumer drug advertising spend.
• Across the 150 top-selling branded US drugs in 2020, a median 13.5 percent of promotional spending went to consumers rather than clinicians.

What those advertisements actually contain

The industry's standing defence of this arrangement is education: the advertisements inform patients, who then have better conversations with their doctors. It is a reasonable argument and it has been tested. A content analysis of 61 prime-time prescription drug television advertisements found only 16 percent conveyed the risk factors for the condition being targeted and only 16 percent conveyed how common it was, while 94 percent leaned on positive emotional appeals and most showed the medication enabling recreational activities [5]. Separately, an experiment with 180 participants found that exposure to this style of advertising did not increase knowledge of treatment side effects, which is the specific thing the education argument promises [6]. The advertisements are doing something. On the evidence, it is not mainly teaching.

The conflict is structural, and it does not require anyone to be dishonest

Now put those two facts beside each other, because this is the whole argument. Outlets that carry health coverage are, in part, funded by the companies whose products that coverage sits next to. That is a conflict of interest in the ordinary, technical sense of the phrase: a relationship that creates pressure on judgment. It does not mean any particular story was bought, and it does not mean any journalist has been leaned on. It means the incentive runs one way and never the other. There is no revenue line for coverage that concludes you probably do not need anything. Sleep, sunlight, movement, food, company and time have no advertising budget, no salesforce and nobody to buy a slot. That asymmetry is enough to shape a catalog on its own, which is exactly the mechanism the companion post on attention markets describes.

Where we stop citing and start stating

Everything above is documented and linked. What follows is this site's position, stated as a position, and you should weigh it as one. Chronic illness, considered purely as a market, is the most valuable customer relationship in commerce: recurring, non-discretionary, priced without meaningful competition, and lasting decades. Follow that arithmetic to its end and a sick child is pure economic fact -- the highest net value resource, because the horizon is longest. That sentence is deliberately hard to read, and it is meant to be. We think it has to be said out loud, because it is the thing the polite version of this conversation is always circling and never naming. Be precise about what it claims: it is a statement about how an incentive structure values a life over time. It is not a claim that anyone wants children to be ill, and we are not making that claim. Doctors, nurses, researchers and the overwhelming majority of people working inside these industries are trying to help, and most of them have never once thought about any of this. The structure does not need their consent to point where it points.

The reason we say it in plain language

There is a version of this argument that hides inside softer words -- misaligned incentives, market dynamics, commercial pressures -- and stays comfortable enough that nothing lands. We think naming it plainly is the more honest move, and it is the same move the rest of this site makes: say the documented part with the receipts attached, say the argued part in the first person, and never let the second borrow the authority of the first. If you disagree with the argued part, you should be able to see exactly which sentence you are disagreeing with. That is what keeping them apart is for.

What actually helps

None of this makes medicine the enemy, and prevention is not a substitute for care you genuinely need. What it changes is the question you bring to health information. Ask who paid for the thing in front of you, which is usually findable in a minute. Ask whether it is telling you something about your body or moving you toward a purchase, and notice that a good answer is often both. Then put most of your weight where no advertising budget exists, because that is where the returns are least contested and least promoted: how you sleep, how you move, what you eat, how much daylight you get, and who you spend time with. Nobody is going to buy a television slot to tell you that.

• Ask who funded the message before you act on it. It is usually one search away.
• Treat an emotional appeal as a marketing signal, not a health signal -- 94 percent of analysed drug ads used one.
• Remember what has no advertising budget: sleep, daylight, movement, whole food, company, time.
• Prevention is not a replacement for care you need. It is the part nobody is paid to sell you.